Research Project

Project Title:	A reactogenicity, safety and immunogenicity study of GSK’s paediatric Herpes Zoster subunit candidate vaccine (PED-HZ/su) GSK143713A in immunocompromised paediatric renal transplant recipients.
Project Type:	Clinical Trial, Enrolment ongoing
Disease group(s):	Pediatric kidney transplantation
Project Summary:	A Phase II, randomised, open-label, multicentre study to assess the reactogenicity, safety and immunogenicity of GSK's paediatric Herpes Zoster subunit candidate vaccine (PED-HZ/su) when administered intramuscularly on a two-dose schedule to immunocompromised paediatric renal transplant recipients from 1 to 17 years of age.
Lead principal investigator(s):	Giovanni Montini, Milan
Co-investigator(s):	Sara Testa, Milan
Project Period:	09/2019 - 12/2023
Sponsors:	Industry
EudraCT Nr.:	2019-000607-33